SMAD4-independent activation of TGF-β signaling by MUC1 in a human pancreatic cancer cell line
Priyanka Grover(University of North Carolina at Charlotte), Pinku Mukherjee(University of North Carolina at Charlotte), Mohammad Ahmad(University of North Carolina at Charlotte), Sritama Nath(University of North Carolina at Charlotte), Ru Zhou(University of British Columbia), Monica D. Nye(Novel (United States))
Cited by 29
Related Papers
Three-dimensional culture systems in cancer research: Focus on tumor spheroid model
|Pharmacology & Therapeutics|2016|921
MUC1: a multifaceted oncoprotein with a key role in cancer progression
|Trends in Molecular Medicine|2014|854
MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition
|Oncogene|2010|269
MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes
|Oncogenesis|2013|176
Discovery of 1-{(3<i>R</i>,4<i>R</i>)-3-[({5-Chloro-2-[(1-methyl-1<i>H</i>-pyrazol-4-yl)amino]-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}prop-2-en-1-one (PF-06459988), a Potent, WT Sparing, Irreversible Inhibitor of T790M-Containing EGFR Mutants
|Journal of Medicinal Chemistry|2016|93